[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

Trivedi et al., 2019 - Google Patents

Consciousness energy healing treatment: Impact on the physicochemical and thermal properties of ascorbic acid

Trivedi et al., 2019

View PDF
Document ID
10733631821236943209
Author
Trivedi D
Trivedi M
Branton A
Nayak G
Jana S
Publication year
Publication venue
Food Nutr Current Res

External Links

Snippet

Ascorbic acid is widely known for its role as an antioxidant and enzyme cofactor and it plays a dynamic role in maintaining good health. The study was performed on the test samples to determine the impact of the Consciousness Energy Healing Treatment (Trivedi Effect®) on …
Continue reading at www.researchgate.net (PDF) (other versions)

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/455—Nicotinic acids, e.g. niacin; Derivatives thereof, e.g. esters, amides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. cannabinols, methantheline
    • A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A61K31/355—Tocopherols, e.g. vitamin E
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic, hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/34—Copper; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/12—Ketones
    • A61K31/122—Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation; Therapies using these preparations
    • A61K41/0004—Homeopathy; Vitalisation; Resonance; Dynamisation, e.g. esoteric applications; Oxygenation of blood
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form

Similar Documents

Publication Publication Date Title
US9610255B2 (en) Lycopene and resveratrol dietary supplement
Trivedi et al. Consciousness energy healing treatment: Impact on the physicochemical and thermal properties of ascorbic acid
Nayak et al. Evaluation of the effect of consciousness energy healing treatment on the physicochemical and thermal properties of selenium
CN101348461B (en) N-(3-pyridine formyloxy)-3,5-dimethyl-1-amantadine for curing senile dementia or pharmaceutical salt thereof
Nayak et al. The energy of consciousness healing treatment: Impact on physicochemical and thermal properties of l-tryptophan
CN104306423B (en) Application of the Saussurea involucrata culture in the product for suppressing cutaneous pigmentation is prepared
Nayak et al. Physicochemical and thermal properties of consciousness energy healing treated hydroxypropyl β-cyclodextrin
Nayak et al. Consciousness energy healing treatment: Impact on the physicochemical and thermal characteristics of folic acid
Branton et al. Solid State Characterization for a Comparative Evaluation of the Biofield Energy Treated and Un-treated Ascorbic Acid
Branton et al. The Effect of Consciousness Energy Healing Treatment on the Physico-chemical and Thermal Properties of L-Cysteine
Branton et al. Characterization of the Consciousness Energy Healing Treated Essential Amino Acid: L-Tryptophan
Branton et al. EFFECT OF CONSCIOUSNESS ENERGY HEALING TREATMENT ON PHYSICOCHEMICAL PROPERTIES OF L-TRYPTOPHAN: A NOVEL POLYMORPHIC FORM FOR IMPROVED NUTRACEUTICALS
Nayak et al. Physicochemical and thermal characterization of ascorbic acid: Impact of biofield energy treatment
CN102342949A (en) Application of phlorhizin in preparation of drug for treating hyperuricemia
Trivedi Evaluation of the physicochemical and thermal properties of folic acid: Influence of the energy of consciousness healing treatment
Branton et al. Evaluation of the physicochemical and thermal properties of consciousness energy healing treated cefazolin sodium
Trivedi et al. Consciousness energy healing treatment: Impact on physicochemical and thermal properties of zinc
CN102138894B (en) Stable large-capacity fasudil hydrochloride injection
Trivedi et al. Con-sciousness Energy Healing Treatment Influenced the Physicochemical and Thermal Properties of Berberine Chloride
Trivedi et al. Evaluation of consciousness energy healing treated pyridoxine (vitamin B6)
Trivedi et al. Particle Size, Surface Area, Crystallite Size, and Thermal Analysis of Consciousness Energy Healing Treated Selenium
Trivedi et al. Physicochemical, Thermal, and Spectroscopic Characterization of the Consciousness Energy Healing Treated Cholecalciferol
Mahendra et al. Assessment of Physical, Thermal and Spectral Properties of the Consciousness Energy Healing Treated Magnesium Gluconate
Trivedi et al. Solid State Characterization of Consciousness Energy Healing Treated Magnesium Gluconate using PXRD, PSA, DSC and TGA/DTG Analysis
Radeef et al. Piracetam And Citicoline Effect on The General Anesthesia Animals Model